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Bcl2/Bax ratios in chronic lymphocytic leukaemia and
their correlation with in vitro apoptosis and clinical
resistance
Sir,
We were interested to read the recent article by Pepper et al (Br J
Cancer 76: 935-938, 1997). This paper discussed flow cytometric
quantitation of apoptosis as a measure of responsiveness to
chemotherapy in B-cell chronic lymphocytic leukaemia (B-CLL),
with particular reference to Bcl-2/Bax protein ratios. Our group,
using the same antibodies, is pursuing very similar research in
superficial bladder cancer. We have compared percentages ofposi-
tively staining Bcl-2 and Bax tumour cells before and after in vitro
exposure to mitomycin C in bladder tumours. We have obtained
results (unpublished) which would further support the theory that
Bax dysregulation plays an important role in chemoresistant
tumours (Boersma et al, 1997; Chresta et al, 1996).
As the next stage to our own experiments, we would be very
keen to investigate co-expression of Bcl-2 and Bax in the
bladder tumour cells using flow cytometry. Co-expression
would indicate the extent of heterodimerization of Bcl-2 with
Bax that is likely to affect the inhibition of apoptosis after
chemotherapy (Yang et al, 1995). We were therefore very inter-
ested to read the authors' description of a triple-colour flow
cytometry methodology in B-CLL cells. They described how
they sequentially incubated the cells with anti-CD19 Cy5 PE-
conjugated antibody, Bcl-2 FITC and Bax followed by PE-
labelled secondary antibody. Unfortunately, the authors did not
report their findings on the co-expression of Bcl-2 and Bax in the
B-CLL cells.
Secondly, the paper did not report the Bcl-2 and Bax protein
levels in their clinically untreated patient samples after in vitro
exposure to chlorambucil. Considering our own findings, which
showed a correlation between apoptotic index > 10% and
increased Bax protein, these data would have been very relevant.
Thirdly, we were confused by the fact that the authors confirmed
that the Annexin V-positive Iymphocytes cells were apoptotic by
morphological assessment. Annexin V binds to cells in the early
stages ofapoptosis, are not all likely to exhibit the classical features
of apoptosis (Martin et al, 1995). It would be interesting to know
what criteria the authors used to confirm that the Annexin V-posi-
tive lymphocytes were or were not in early apoptosis.
In summary, the authors designed an important study, but unfor-
tunately they did not exploit or report all oftheir data.
KE Williamson', JD Kelly2, PWHamilton', D McManus'
and SR Johnston2
Departments of'Pathology and2Surgery; The Queen's University
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Bcl2/Bax ratios in chronic lymphocytic leukaemia and
their correlation with in vitro apoptosis and clinical
responsiveness - reply
Sir,
The quantification of Bcl-2 and Bax proteins was achieved by
triple-colour analysis as described in our paper, and the co-expres-
sion of Bcl-2 and Bax was measured in these experiments.
However, our data relate to protein expression in the total gated
B-lymphocyte population of cells rather than to individual cell
analysis; all gated cells expressed both Bcl-2 and Bax proteins.
The index we used to describe this co-expression was a ratio ofthe
two proteins (Bcl-2/Bax) as there is evidence that the ratio ofdeath
promoters to death inhibitors within the cell may determine
susceptibility to death signals (Korsmeyer et al, 1993; Thomas
et al, 1996; Pepper et al, 1996). These ratios were calculated as
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